1999 - PhD in Pharmaceutics: West China University of Medical Sciences
Published over 220 academic papers, including more than 120 SCI papers
Authored or co-authored 10 textbooks or monographs
1999-2001 - Shanghai Institute of Materia Medica - Senior Engineer
2001-2005 - Shanghai Institute of Materia Medica - Executive Deputy Director
2005-present - Fudan University - Various roles including Deputy Dean and Party Secretary
2009-2010 - University of Michigan - Visiting Scholar
2002: First Prize for Excellent Paper at the 6th National Conference of Young Pharmaceutical Scientists
2002: Top Ten Advanced Individuals in Shanghai
2003: Shanghai New Long March Pioneer
2004: Shanghai Model Worker
2011: Chinese Pharmaceutical Association - Shiyao Group Young Pharmaceutical Award
2014: Shanghai Excellent Technical Leader
2017: Second Prize for Excellent Project in Shanghai Industry-University-Research Cooperation
2018: First Prize in the First Renwei MOOC Online Open Course Construction Competition
2018: Third Prize in Sichuan Science and Technology Progress Award
2018: Shanghai Education System Excellent Model Worker Studio
2021: Shanghai Model Worker Innovation Studio
2023: Second Prize of the 'One Health Fund' Excellent Teacher Award
Research
Targeted Drug Delivery Systems Based on Disease Pathology Design and Absorption Mechanisms of Oral Drug Delivery Systems Research on New Drug Delivery Systems for Traditional Chinese Medicine Development of New Drug Formulations and Dosage Forms
Selective Ischemic-Hemisphere Targeting Ginkgolide B Liposomes with Improved Solubility and Therapeutic Efficacy for Cerebral Ischemia-Reperfusion Injury, Yang Li, Miaomiao Zhang, Shiyi Li, Longlong Zhang, Jisu Kim, Qiujun Qiu, Weigen Lu, Jianxin Wang, 2023
Paclitaxel-Loaded Ginsenoside Rg3 Liposomes for Drug-Resistant Cancer Therapy by Dual Targeting of the Tumor Microenvironment and Cancer Cells, Ying Zhu, Anni Wang, Shuya Zhang, Jisu Kim, Jiaxuan Xia, Fengxue Zhang, Dan Wang, Qi Wang, Jianxin Wang, 2023
Dual-Sensitive Drug-Loaded Hydrogel System for Local Inhibition of Post-Surgical Glioma Recurrence, Sunhui Chen, Qiujun Qiu, Dongdong Wang, Dejun She, Bo Yin, Guolong Gu, Meihong Chai, Dong Nyoung Heo, Huining He, Jianxin Wang, 2022
One Stone Four Birds: A Novel Liposomal Delivery System Multi-Functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy, Chao Hong, Jianming Liang, Jiaxuan Xia, Ying Zhu, Yizhen Guo, Anni Wang, Chunyi Lu, Hongwei Ren, Chen Chen, Shiyi Li, Dan Wang, Huaxing Zhan, Jianxin Wang, 2020
Menthol-Modified Bsa Nanoparticles for Glioma Targeting Therapy Using an Energy Restriction Strategy, Jianming Liang, Ying Zhu, Caifang Gao, Chengli Ling, Jing Qin, Qi Wang, Yongzhuo Huang, Weigen Lu, Jianxin Wang, 2019
Accessing Neuroinflammation Sites: Monocyte/ Neutrophil- Mediated Drug Delivery for Cerebral Ischemia, Jia Hou, Xu Yang, Shiyi Li, Zhekang Cheng, Yuhua Wang, Jing Zhao, Chun Zhang, Yongji Li, Man Luo, Hongwei Ren, Jianming Liang, Jue Wang, Jianxin Wang, Jing Qin, 2019
A Novel Tumor-Targeting Treatment Strategy Uses Energy Restriction Via Co-Delivery of Albendazole and Nanosilver, Jianming Liang, Ruixiang Li, Yuwei He, Chengli Ling, Qi Wang, Yongzhuo Huang, Jing Qin, Weigen Lu, Jianxin Wang, 2018
Sustained Release of Immunosuppressant by Nanoparticle-Anchoring Hydrogel Scaffold Improved the Survival of Transplanted Stem Cells and Tissue Regeneration, Ruixiang Li, Jianming
Keywords
Targeted Drug DeliveryDisease PathologyOral Drug DeliveryAbsorption MechanismsTraditional Chinese MedicineNew Drug Delivery SystemsDrug FormulationsDosage FormsPharmaceuticsNanotechnology
Area of Focus
Traditional Chinese Medicine | New Drug Development | Dosage Forms | Natural Medicines | Active Ingredients | Quality Evaluation | Compound Formulas | Efficacy Substances | Pharmacology | Herbal Medicine